Osaka Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 7.93 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 81.61 Cr
- Satisfied Charges ₹ 5.00 Cr
- Revenue Growth 11.39%
- Profit Growth -77.84%
- Ebitda 211.49%
- Net Worth 4.03%
- Total Assets -2.20%
About Osaka Pharmaceuticals
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2004PTC043750
-
Company No.
043750
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2004
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Osaka Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Bhandari
|
Director | 17-May-2023 | Current |
|
Sachin Bhandari
|
Director | 17-May-2023 | Current |
Financial Performance of Osaka Pharmaceuticals.
Osaka Pharmaceuticals Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 11.39% increase. The company also saw a substantial fall in profitability, with a 77.84% decrease in profit. The company's net worth moved up by a moderate rise of 4.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osaka Pharmaceuticals?
Unlock access to Osaka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹81.61 Cr
₹5.00 Cr
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 81.47 Cr
- Electronica Finance Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2014 | Electronica Finance Limited | ₹1.43 M | Open |
| 08 Jun 2013 | Oriental Bank Of Commerce | ₹3.50 Cr | Open |
| 27 Dec 2011 | Oriental Bank Of Commerce | ₹26.68 Cr | Open |
| 09 Jun 2011 | Oriental Bank Of Commerce | ₹4.00 Cr | Open |
| 09 Jun 2011 | Oriental Bank Of Commerce | ₹20.60 Cr | Open |
How Many Employees Work at Osaka Pharmaceuticals?
Osaka Pharmaceuticals has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osaka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osaka Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
